盐酸溴己新 T0828

Product Introduction
Bioactivity


英文名: Bromhexine hydrochloride

描述: Bromhexine hydrochloride (Bisolvon) 是TMPRSS2蛋白酶的一种特异性有效抑制剂，IC50为 0.75 μM。它可预防和控制SARS-CoV-2感染。它是一种粘液溶解剂，用于治疗与粘稠或过多粘液相关的呼吸系统疾病。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 5.63 mg/mL (13.63 mM)
Ethanol : 5 mg/mL (12.11 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)


关键字: SARS coronavirus | Bromhexine hydrochloride | respiratory | HIV | conditions | Autophagy | Bromhexine Hydrochloride | SARS-CoV | TMPRSS2 | inhibit | mucolytic | Human immunodeficiency virus | cough | Inhibitor | suppressant | Bromhexine

相关产品: TC-067533 | Plutavimab | Z-FA-FMK | Atazanavir sulfate | MAT-POS-e194df51-1 | SARS-CoV-2-IN-61 | GRL-0496 | SARS-CoV-2-IN-43 | SSAA09E3 | Thapsigargin

相关库: Drug Repurposing Compound Library | Approved Drug Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Ferroptosis Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Autophagy Compound Library | NO PAINS Compound Library | Anti-Viral Compound Library

盐酸溴己新 T0828信息由TargetMol中国为您提供，如您想了解更多关于盐酸溴己新 T0828报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途